Clinical trials
Phase 2 Carcinoma, Transitional Cell trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Unknown status | 10 |
| Completed | 5 |
| Not yet recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| RemeGen Co., Ltd. | 3 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 3 |
| Abbisko Therapeutics Co, Ltd | 2 |
| Fudan University | 2 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| Tianjin Medical University Second Hospital | 2 |
| Akeso | 1 |
| Chinese Academy of Medical Sciences | 1 |
| Chinese PLA General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 30 |
| Urinary Bladder Neoplasms | 5 |
| Angiomyolipoma | 1 |
| Basal Cell Carcinoma | 1 |
| Biliary Tract Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma in Situ | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.